Related Experiment Videos
On a "chalone"-like factor for Ehrlich ascites mammary carcinoma
Acta Biologica Et Medica Germanica
|January 1, 1980
Summary
A novel growth inhibitory factor from bovine mammary glands specifically halts Ehrlich ascites mammary carcinoma (EAC) cell proliferation by blocking G1 to S-phase transition. Insulin counteracts this effect, suggesting a role in cancer growth regulation.
Area of Science:
- Biochemistry
- Cell Biology
- Oncology
Background:
- Ehrlich ascites mammary carcinoma (EAC) cells exhibit complex growth regulation.
- Understanding endogenous factors influencing tumor cell proliferation is crucial for developing targeted therapies.
Purpose of the Study:
- To identify and characterize a novel factor involved in the growth regulation of EAC cells.
- To elucidate the mechanism of action and potential therapeutic implications of this factor.
Main Methods:
- Preparation of aqueous ultrafiltrate from EAC cells, ascites fluid, and bovine mammary gland.
- In vitro cell culture assays to assess proliferation inhibition.
- Flow cytometry and tritiated thymidine labeling for cell cycle analysis.
- Purification using ultrafiltration and affinity chromatography.
- Enzyme and heat stability assays.
Main Results:
- A novel factor was isolated that reversibly inhibits EAC cell proliferation, particularly affecting stationary cells.
- The factor appears to block G1-phase progression into S-phase.
- Insulin and proinsulin counteract the inhibitory effect.
- The factor's activity is heat-labile and trypsin-sensitive.
- Purification yielded an 800-fold enrichment, with over 100,000-fold purification from the initial homogenate.
Conclusions:
- A potent growth inhibitory factor for EAC cells exists in bovine mammary gland extracts.
- This factor represents a potential target for anti-cancer strategies.
- The interaction with insulin suggests a link between metabolic regulation and tumor growth control.